February 2024

Economic boost from science

RAYDIAX, as a company that emerged from a #science #transfer from the Forschungscampus STIMULATE / Otto-von-Guericke-Universität Magdeburg and is financed by private and institutional investors, is a #sparring #partner for new start-up initiatives.

Dr. Thomas Hoffmann, CEO of RAYDIAX GmbH: "As a founding member of Business Angels Sachsen-Anhalt e.V., we are delighted to support future start-ups with the experience we have gained so far in science transfer. In particular, we believe it is important to help shape a lively association in Saxony-Anhalt that is committed to the region and gives young entrepreneurs the opportunity to turn their passion into reality."

Last Articles

Stay informed!

Join our newsletter to stay informed about our latest updates, valuable technical and clinical insights and future events directly in your inbox. Follow our journey to revolutionize the world of minimally invasive therapies.
Sign up today and become part of our community!

Ready for Innovation?

We know that the methods of minimally invasive therapies continue to offer great potential for clinical innovation. Would you also like to establish your operating technique? Make a suggestion, define a joint project and research your case on our system in phantom studies. And of course we are open to clinical publications.